Select Publications
Journal articles
2018, 'P571 Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC)', Journal of Crohn's and Colitis, 12, pp. S395 - S396, http://dx.doi.org/10.1093/ecco-jcc/jjx180.698
,2017, 'Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases', Alimentary Pharmacology and Therapeutics, 46, pp. 1037 - 1053, http://dx.doi.org/10.1111/apt.14368
,2017, 'P691 UV exposure and skin type are more important than thiopurine exposure for non-melanoma skin cancer risk in IBD', Journal of Crohn's and Colitis, 11, pp. S433 - S434, http://dx.doi.org/10.1093/ecco-jcc/jjx002.815
,2017, 'UV Exposure and Skin Type are More Important than Thiopurine Exposure for Non-Melanoma Skin Cancer Risk in IBD', Gastroenterology, 152, pp. S576 - S576, http://dx.doi.org/10.1016/s0016-5085(17)32082-6
,2017, 'UV Irradiation of Skin Enhances Glycolytic Flux and Reduces Migration Capabilities in Bone Marrow-Differentiated Dendritic Cells.', Am J Pathol, 187, pp. 2046 - 2059, http://dx.doi.org/10.1016/j.ajpath.2017.06.003
,2016, 'Conflict of interest: Real and perceived - a more mature consideration is needed', Internal Medicine Journal, 46, pp. 377 - 379, http://dx.doi.org/10.1111/imj.12989
,2016, 'High Vitamin D-Binding Protein Concentration, Low Albumin, and Mode of Remission Predict Relapse in Crohn's Disease.', Inflamm Bowel Dis, 22, pp. 2456 - 2464, http://dx.doi.org/10.1097/MIB.0000000000000894
,2015, 'Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: The benefits to patients', Internal Medicine Journal, 45, pp. 659 - 666, http://dx.doi.org/10.1111/imj.12732
,2015, 'Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response', Internal Medicine Journal, 45, pp. 170 - 177, http://dx.doi.org/10.1111/imj.12621
,2015, 'Su1268 Serum Vitamin D Binding Protein Concentration Is Associated With Disease Flare in a Cohort of Patients in Crohn's Disease Remission', Gastroenterology, 148, pp. S - 456, http://dx.doi.org/10.1016/s0016-5085(15)31539-0
,2014, 'Short term dose tailoring of anti TNF-alpha therapy delivers useful clinical efficacy in Crohn's disease patients with secondary loss of response', JOURNAL OF CROHNS & COLITIS, 8, pp. S209 - S209, http://dx.doi.org/10.1016/S1873-9946(14)60466-9
,2014, 'The role of vitamin D in gastrointestinal inflammation.', Expert Rev Gastroenterol Hepatol, 8, pp. 909 - 923, http://dx.doi.org/10.1586/17474124.2014.925796
,2008, 'Audit of endometrial biopsy at outpatient hysteroscopy', Australian and New Zealand Journal of Obstetrics and Gynaecology, 48, pp. 202 - 206, http://dx.doi.org/10.1111/j.1479-828X.2008.00834.x
,Conference Papers
2019, 'Multinational comparisons of practices in overseas travel in Crohn's disease and ulcerative colitis', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Copenhagen, Denmark, pp. S267 - S267, presented at ECCO, Copenhagen, Denmark, 06 March 2019 - 09 March 2019, http://dx.doi.org/10.1093/ecco-jcc/jjy222.456
,2014, 'Compassionate access use of anti-TNF therapy in ulcerative colitis in six Australian IBD centres has been beneficial to patient outcomes', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, pp. S288 - S288, http://dx.doi.org/10.1016/S1873-9946(14)60649-8
,2012, 'Hepatocellular Carcinoma Risk In Chronic Hepatitis B Patients Achieving Viral Suppression With Antiviral Therapy', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 354A - 354A, presented at 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 09 November 2012 - 13 November 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310955601331&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Posters
2020, 'P586 Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease', Vol. 14, pp. S490 - S491, http://dx.doi.org/10.1093/ecco-jcc/jjz203.714
,Conference Abstracts
2023, 'Comparing long-term outcomes in inflammatory bowel disease patients between switch and non-switch cohorts: no differences in infliximab persistence or safety outcomes after 54 months', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 884 - 884, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601460&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2023, 'Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 17, pp. 542 - 542, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000960367601125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'HISTOLOGICAL REMISSION USING A NANCY INDEX OF 0 IS ASSOCIATED WITH LONGER RELAPSE-FREE SURVIVAL THAN HISTOLOGICAL ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION', in GUT, BMJ PUBLISHING GROUP, Vol. 71, pp. A149 - A150, http://dx.doi.org/10.1136/gutjnl-2022-IDDF.207
,2021, 'LYOPHILIZED ORALLY ADMINISTERED FECAL MICROBIOTA TRANSPLANTATION IN THE MANAGEMENT OF ULCERATIVE COLITIS (LOTUS STUDY) - RESULTS FROM THE INDUCTION PHASE OF A RANDOMIZED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, ELECTR NETWORK, Vol. 160, pp. S135 - S135, presented at Society-for-Surgery-of-the-Alimentary-Tract Annual Meeting at Digestive Disease Week (DDW), ELECTR NETWORK, 21 May 2021 - 23 May 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000649085000323&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Bone loss is common but under-screened in patients with inflammatory bowel disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 128 - 128, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200185&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Sa1913 CONSENSUS GUIDELINES FOR THE REGULATION, PRODUCTION AND USE OF FECAL MICROBIOTA TRANSPLANTATION IN CLINICAL PRACTICE', in Gastroenterology, Elsevier BV, Vol. 158, http://dx.doi.org/10.1016/s0016-5085(20)31872-2
,2019, 'Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn's disease', in JOURNAL OF CROHNS & COLITIS, OXFORD UNIV PRESS, Vol. 13, pp. S374 - S374, http://dx.doi.org/10.1093/ecco-jcc/jjy222.647
,Reports
2016, Iron and vitamin D deficiency in inflammatory bowel disease, http://dx.doi.org/10.1111/jgh.13359
,Preprints
2024, The primary sclerosing cholangitis and ulcerative colitis colonic mucosa defined through paired microbial and single-cell RNA sequencing, http://dx.doi.org/10.1101/2024.08.12.607536
,Lyophilised Oral Faecal Microbiota Transplantation in Ulcerative Colitis - a Randomised Placebo-Controlled Trial, http://dx.doi.org/10.2139/ssrn.3931753
,